Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (6535)	6/23/1998 8:26:00 AM
From: opalapril	Read Replies (1) \| Respond to of 17367

It occurs to me the "adult" trial might be a natural offshoot of the child trials. For example, I understand that in one severe recent meningo case (apparently not in connection with any Xoma trial) involving a teenage boy treating physicians insisted on prophylactic treatment of all close relatives -- sibling, parents, etc. -- and friends. Likewise, press reports in the Iowa City case I mentioned earlier -- which I now take it also does not involve Xoma trials -- mentioned that college roommates and close friends of the victim were being given preventive treatment. In such cases it makes good sense to administer rBPI too, am I right? As for Ellen Martin, sheeeesh. Isn't it a little strong to criticize her? She's only an IR/PR person. I don't know for sure, but I very much doubt people at such a level are allowed to make ad hoc decisions re: public disclosure of relevant information. Probably, they operate under explicit policy guidelines limiting releases in the first instance to company-authorized statements and reports, in the second instance to executive- and legal office-approved FAQs and what have you, and in the third instance to published monographs or news reports involving staff or affiliated scientists. Anything else would require direct authorization, I would imagine. Tharos' ferret work certainly is inspiring. Let's be grateful for Tharos without spitting on Ellen, okay?

To: Robert K. who wrote (6535)	6/23/1998 8:51:00 AM
From: Tharos	Respond to of 17367

I agree with you assesment on beating up Ellen. She has been doing a bang-up job and quick to contact anyone who has old data about Xoma as current. I know because I have passed along the URLs and within days they were fixed. With out meaning to demean Ellen or her position, I also agree that she cannot arbitrarily release info. So..... We are paying our CEO a very handsome salary. I don't mind paying the salary, and feel a person should be able to earn as much as they can; however, our CEO could do a better job of keeping us up to date on info. Lets face it, either he decided to not release the info, which says he is willing to hide data from us, or he was not aware of this information delivered in a public forum by the UK Meningitis Foundation. As long as he is a slacker in this area, he should consider stopping outside, distracting activities, such as being on the board of directors in another company, until he gets his act together. You can pass that on to him, Ellen; he is after all only an employee, while I am a partial owner of the firm. My next complaint for failure to release information goes to the SEC. Tharos

To: Robert K. who wrote (6535)	6/23/1998 9:01:00 PM
From: Robert K.	Respond to of 17367

Post 6535.................1 down, 3 to go...............................................>> >>1. Orphan status 2. liver results. 3. New indication announced 4. capitial being raised. Then of course september is a coming, for better or for worse.